ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,039.31
-0.47%
US Tech 100
20,929.20
0.46%
다우존스 지수
44,713.52
-0.31%
Bitcoin
105,235.05
1.44%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Hutchmed (china) Limited (HCM)

  7. Hutchmed (china) Limited (HCM) 뉴스

HCM

Hutchmed (china) (HCM)

Hutchmed (china) Limited
일자:
정렬 기준:
 검색 관련기사 보기:LSE:HCM
일자시간출처헤드라인심볼기업
2025/01/2818:00RNS Regulatory NewsHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:HCMHutchmed (china) Limited
2025/01/1421:07Alliance NewsAlliance NewsIN BRIEF: Hutchmed lung cancer treatment Orpathys approved in ChinaLSE:HCMHutchmed (china) Limited
2025/01/1416:00RNS Non-RegulatoryHutchmed (China) Limited Full Approval for ORPATHYS in ChinaLSE:HCMHutchmed (china) Limited
2025/01/0219:46Alliance NewsAlliance NewsHutchmed China disposes of 45% stake in Shanghai joint ventureLSE:HCMHutchmed (china) Limited
2025/01/0216:01RNS Non-RegulatoryHutchmed (China) Limited China NDA Acceptance for ORPATHYS and TAGRISSOLSE:HCMHutchmed (china) Limited
2025/01/0216:00RNS Regulatory NewsHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:HCMHutchmed (china) Limited
2025/01/0216:00RNS Regulatory NewsHutchmed (China) Limited US$608m Divestment of Non-Core Joint VentureLSE:HCMHutchmed (china) Limited
2024/12/3117:30RNS Regulatory NewsHutchmed (China) Limited Appointment of Joint Corporate BrokerLSE:HCMHutchmed (china) Limited
2024/12/3017:30RNS Regulatory NewsHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:HCMHutchmed (china) Limited
2024/12/1319:04Alliance NewsAlliance NewsIN BRIEF: Hutchmed to get Takeda milestone paymentLSE:HCMHutchmed (china) Limited
2024/12/1316:00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Receive Milestone Payment from TakedaLSE:HCMHutchmed (china) Limited
2024/12/1216:00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation in ChinaLSE:HCMHutchmed (china) Limited
2024/12/0321:19Alliance NewsAlliance NewsHutchmed China injection approval could be a "paradigm shift"LSE:HCMHutchmed (china) Limited
2024/12/0319:00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and Innovent Announce ELUNATE ApprovalLSE:HCMHutchmed (china) Limited
2024/11/2917:30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
2024/11/2819:32RNS Non-RegulatoryHutchmed (China) Limited Continued Inclusion of ORPATHYS in China NRDLLSE:HCMHutchmed (china) Limited
2024/11/2219:00Alliance NewsAlliance NewsHutchmed to get payment from Takeda as Fruzaqla launched in JapanLSE:HCMHutchmed (china) Limited
2024/11/2216:00RNS Non-RegulatoryHutchmed (China) Limited FRUZAQLA® Launched in Japan by TakedaLSE:HCMHutchmed (china) Limited
2024/11/2018:30RNS Regulatory NewsHutchmed (China) Limited Appointment of Independent Non-executive DirectorLSE:HCMHutchmed (china) Limited
2024/11/0616:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASH and ESMO AsiaLSE:HCMHutchmed (china) Limited
2024/10/3121:02Alliance NewsAlliance NewsHutchmed China receives first milestone payment for Takeda drug salesLSE:HCMHutchmed (china) Limited
2024/10/3117:30RNS Regulatory NewsHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
2024/10/3117:30RNS Non-RegulatoryHutchmed (China) Limited First Commercial Milestone PaymentLSE:HCMHutchmed (china) Limited
2024/10/2117:30RNS Regulatory NewsHutchmed (China) Limited Vesting of awards under the LTIPLSE:HCMHutchmed (china) Limited
2024/10/1617:52Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising resultsLSE:HCMHutchmed (china) Limited
2024/10/1615:00RNS Regulatory NewsHutchmed (China) Limited SAVANNAH: clinically meaningful response rateLSE:HCMHutchmed (china) Limited
2024/09/2416:49Alliance NewsAlliance NewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backingLSE:HCMHutchmed (china) Limited
2024/09/2416:00RNS Regulatory NewsHutchmed (China) Limited Japan Approval for FRUZAQLALSE:HCMHutchmed (china) Limited
2024/09/0915:00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO and WCLCLSE:HCMHutchmed (china) Limited
2024/08/3020:24Alliance NewsAlliance NewsHutchmed "disappointed" as it withdraws fruquintinib applicationLSE:HCMHutchmed (china) Limited
 검색 관련기사 보기:LSE:HCM

최근 히스토리

NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
NYSE
AXP
American Express
CCOM
US500
US 500
NYSE
KO
Coca Cola
COIN
AVAXUSD
Avalanche
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
FX
USDEUR
US Dollar vs Euro
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지